BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21620981)

  • 1. Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls.
    Raznahan A; Greenstein D; Lee Y; Long R; Clasen L; Gochman P; Addington A; Giedd JN; Rapoport JL; Gogtay N
    Neuroimage; 2011 Aug; 57(4):1517-23. PubMed ID: 21620981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
    Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.
    Li ML; Xiang B; Li YF; Hu X; Wang Q; Guo WJ; Lei W; Huang CH; Zhao LS; Li N; Ren HY; Wang HY; Ma XH; Deng W; Li T
    Neurosci Bull; 2015 Feb; 31(1):31-42. PubMed ID: 25564193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis.
    McIntosh AM; Baig BJ; Hall J; Job D; Whalley HC; Lymer GK; Moorhead TW; Owens DG; Miller P; Porteous D; Lawrie SM; Johnstone EC
    Biol Psychiatry; 2007 May; 61(10):1127-34. PubMed ID: 17014827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
    Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
    Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
    Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between function and structure of the triple network and catechol-O-methyltransferase val
    Kang Y; Huang K; Cai S; Wang H; Liu J; Wang Y; Lv Y; Zhang W; Wang Q; Huang L; Wang J; Tian J
    Neurosci Lett; 2018 Nov; 687():65-70. PubMed ID: 30240822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia.
    Gogtay N; Greenstein D; Lenane M; Clasen L; Sharp W; Gochman P; Butler P; Evans A; Rapoport J
    Arch Gen Psychiatry; 2007 Jul; 64(7):772-80. PubMed ID: 17606811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
    Shukla AA; Jha M; Birchfield T; Mukherjee S; Gleason K; Abdisalaam S; Asaithamby A; Adams-Huet B; Tamminga CA; Ghose S
    Schizophr Res; 2016 May; 173(1-2):94-100. PubMed ID: 27021555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia.
    Eisenberg DP; Sarpal D; Kohn PD; Meyer-Lindenberg A; Wint D; Kolachana B; Apud J; Weinberger DR; Berman KF
    Biol Psychiatry; 2010 Feb; 67(3):287-90. PubMed ID: 19892319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of catechol-O-methyltransferase val(158)met polymorphism in Saudi schizophrenia patients.
    Al-Asmary S; Kadasah S; Arfin M; Tariq M; Al-Asmari A
    Genet Mol Res; 2014 Apr; 13(2):3079-88. PubMed ID: 24782165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
    Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
    Schizophr Bull; 2010 Jan; 36(1):157-64. PubMed ID: 18562342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
    Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the COMT genotype in the underlying functional brain activity of context processing in schizophrenia and in relatives.
    Lopez-Garcia P; Cristobal-Huerta A; Young Espinoza L; Molero P; Ortuño Sanchez-Pedreño F; Hernández-Tamames JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():176-82. PubMed ID: 27421706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
    Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
    Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
    Apud JA; Weinberger DR
    CNS Drugs; 2007; 21(7):535-57. PubMed ID: 17579498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users.
    Batalla A; Soriano-Mas C; López-Solà M; Torrens M; Crippa JA; Bhattacharyya S; Blanco-Hinojo L; Fagundo AB; Harrison BJ; Nogué S; de la Torre R; Farré M; Pujol J; Martín-Santos R
    Addict Biol; 2014 Jul; 19(4):722-32. PubMed ID: 23311613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic contribution of catechol-O-methyltransferase in dorsolateral prefrontal cortex functional changes in the first episode schizophrenia.
    Kang Y; Huang K; Lv Y; Zhang W; Cai S; Wang Y; Wang Q; Huang L; Wang J; Tian J
    Behav Brain Res; 2019 May; 364():225-232. PubMed ID: 30738913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.
    Wang H; Zhang B; Zeng B; Tang Y; Zhang T; Zhao S; Li C; Wang J; Goff DC
    Schizophr Res; 2018 Sep; 199():214-220. PubMed ID: 29730044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.